Table 2.
Adjusted geometric mean IGF-I concentrations (nmol/l) and 95% CI in 735 controls.
n | Geometric mean and 95% CIa | pdifferenceb | ptrendc | |||
---|---|---|---|---|---|---|
All controls | 735 | 17.1 | 16.8 | 17.5 | – | – |
Sex | ||||||
Male | 164 | 17.5 | 16.7 | 18.3 | ||
Female | 571 | 17.0 | 16.6 | 17.4 | 0.33 | – |
Age at blood collection (years) | ||||||
< 48 | 253 | 19.3 | 18.6 | 20.0 | ||
48–55 | 253 | 16.8 | 16.2 | 17.4 | ||
≥ 56 | 229 | 15.3 | 14.7 | 15.9 | < 0.0001 | < 0.0001 |
Height (cm) | ||||||
<160 | 253 | 17.2 | 16.5 | 17.9 | ||
160–164 | 182 | 17.5 | 16.7 | 18.3 | ||
165–169 | 134 | 17.6 | 16.8 | 18.4 | ||
≥170 | 166 | 16.3 | 15.4 | 17.3 | 0.27 | 0.62 |
Weight (kg) | ||||||
< 60 | 187 | 17.8 | 17.1 | 18.6 | ||
60–69 | 247 | 17.2 | 16.6 | 17.9 | ||
70–79 | 162 | 17.1 | 16.4 | 17.9 | ||
≥ 80 | 139 | 16.1 | 15.3 | 16.9 | 0.04 | 0.01 |
BMI (kg/m2) | ||||||
<22.3 | 147 | 17.5 | 16.7 | 18.3 | ||
22.3–24.4 | 146 | 18.1 | 17.3 | 19.0 | ||
24.4–26.3 | 147 | 17.4 | 16.7 | 18.3 | ||
26.3–28.6 | 148 | 16.8 | 16.0 | 17.6 | ||
> 28.6 | 147 | 15.9 | 15.2 | 16.6 | 0.001 | 0.0003 |
Waist to hip ratiod | ||||||
< 0.76 | 163 | 17.6 | 16.7 | 18.5 | ||
0.76–0.80 | 160 | 17.5 | 16.7 | 18.4 | ||
0.81–0.88 | 195 | 17.3 | 16.6 | 18.0 | ||
≥ 0.89 | 177 | 16.5 | 15.5 | 17.6 | 0.58 | 0.27 |
Alcohol (g/d) | ||||||
0 | 109 | 16.5 | 15.6 | 17.4 | ||
> 0–9 | 381 | 17.2 | 16.8 | 17.7 | ||
10–19 | 133 | 17.0 | 16.2 | 17.9 | ||
≥ 20 | 112 | 17.5 | 16.6 | 18.5 | 0.42 | 0.26 |
Smokingd | ||||||
Never | 392 | 17.2 | 16.7 | 17.7 | ||
Former | 184 | 17.4 | 16.6 | 18.1 | ||
Current | 150 | 16.7 | 16.0 | 17.5 | 0.51 | 0.50 |
Physical activityd | ||||||
Inactive | 195 | 16.8 | 16.1 | 17.5 | ||
Moderately inactive | 279 | 17.1 | 16.6 | 17.7 | ||
Moderately active or active | 241 | 17.5 | 16.9 | 18.1 | 0.37 | 0.16 |
Educationd | ||||||
Less than secondary | 276 | 16.8 | 16.2 | 17.4 | ||
Secondary school | 275 | 17.6 | 17.0 | 18.2 | ||
University degree | 176 | 17.1 | 16.4 | 17.8 | 0.16 | 0.42 |
Menopausal statuse | ||||||
Premenopausal | 212 | 17.2 | 16.3 | 18.2 | ||
Perimenopausal or unknown | 101 | 16.5 | 15.6 | 17.5 | ||
Postmenopausal | 258 | 17.2 | 16.4 | 18.0 | 0.44 | – |
Hormone replacement therapy at blood collectiond,e | ||||||
No | 462 | 17.1 | 16.7 | 17.6 | ||
Yes | 95 | 17.2 | 16.2 | 18.2 | 0.94 | – |
Hours since last meal at blood collection d | ||||||
< 3 | 310 | 17.0 | 16.5 | 17.6 | ||
3–6 | 117 | 16.9 | 16.1 | 17.8 | ||
> 6 | 277 | 17.5 | 17.0 | 18.1 | 0.35 | 0.21 |
Adjusted for age at blood collection (as a continuous variable), BMI (in fifths based on the distribution in controls), and sex, where the adjustment variable was not the variable of interest. Analysis of weight was not adjusted for BMI.
P values refer to tests of difference between the logarithm of IGF-I concentration in the separate categories (excluding unknowns) calculated by analysis of variance.
P values refer to tests of linear trend calculated by scoring categories with consecutive whole numbers (excluding unknowns).
Unknown for some participants.
In women only.